NORCAL CARCINET SUPPORT GROUP (EIN 452968919) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Tax Period

2021-01-01 to 2021-12-31

NORCAL CARCINET SUPPORT GROUP, founded in 2011, is a small nonprofit in the Diseases & Disorders sector that reported $211K in total revenue in fiscal year 2021. Revenue surged 98% from the prior year, signaling strong growth momentum. The organization ran a surplus of $184K, a strong 88% operating margin.

Mission

Our mission is to help those with neuroendocrine tumors and carcinoid to share challenges and experiences learn about prognosis and treatments find information and improve communications between the medical community patients and caregivers. By providing opportunities for our members to connect with others who have these rare illnesses we will enable them not only to get their questions answered but also to give and receive emotional support. In addition we aspire to bring greater awareness to the medical community and the public so as to promote earlier detection and treatment of these often unrecognized illnesses.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $210,648

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $210,648

Expense Breakdown

Grants Paid $2,655

Salaries & Benefits $0

Fundraising Expenses $5,000

Program Expenses $11,137

Other Expenses $23,522

TOTAL EXPENSES $26,177

Year-over-Year Comparison

	2021	2020	Change
Revenue	$210,648	$106,374	+1.0%
Expenses	$26,177	$39,194	-0.3%
Net Income	$184,471	$67,180	+1.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Josh Alan Mailman	President	20.00	Officer Director	$0	$0	$0
Geneva Hayes	Treasurer	2.00	Officer Director	$0	$0	$0
Jerry Magee	Director	2.00	Director	$0	$0	$0
Elizabeth Magee	Director	2.00	Director	$0	$0	$0
Kari Lockey	Director	2.00	Director	$0	$0	$0
David Schrimmer	Director	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2021	$210,648	$26,177	$411,190	$184,471

NORCAL CARCINET SUPPORT GROUP